Paradoxical effects on force generation after efficient β1-adrenoceptor knockdown in reconstituted heart tissue
Publikation: Beitrag in Fachzeitschrift › Forschungsartikel › Beigetragen › Begutachtung
Beitragende
Abstract
Stimulation of myocardial β1-adrenoceptors (AR) is a major mechanism that increases cardiac function. We investigated the functional consequences of genetic b1-AR knockdown in three-dimensional engineered heart tissue (EHT). For β1-AR knockdown, short interfering RNA (siRNA) sequences targeting specifically the β1-AR (shB1) and a scrambled control (shCTR) were subcloned into a recombinant adeno-associated virus (AAV)-short hairpin RNA (shRNA) expression system. Transduction efficiency was ∼100%, and radioligand binding revealed 70% lower β1-AR density in AAV6-shB1-transduced EHTs. Force measurements, performed over the culture period of 14 days, showed paradoxically higher force generation in AAV6-shB1 compared with shCTR under basal (0.19 ± 0.01 versus 0.13 ± 0.01 mN) and after β-AR-stimulated conditions with isoprenaline (Δfractional shortening: 72 ± 5% versus 34 ± 4%). Large scale gene expression analysis revealed that AAV6-shCTR compared with nontransduced EHTs showed only few differentially regulated genes (<20), whereas AAV6-shB1 induced marked changes in gene expression (>250 genes), indicating that β1-AR knockdown itself determines the outcome. None of the regulated genes pointed to obvious offtarget effects to explain higher force generation. Moreover, compensational regulation of β2-AR signaling or changes in prominent β1-AR downstream targets could be ruled out. In summary, we show paradoxically higher force generation and isoprenaline responses after efficient β1- AR knockdown in EHTs. Our findings 1) reveal an unexpected layer of complexity in gene regulation after specific β1-AR knockdown rather than unspecific dysregulations through transcriptional interference, 2) challenge classic assumptions on the role of cardiac β1-AR, and 3) may open up new avenues for β-AR loss-of-function research in vivo.
Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 39-46 |
| Seitenumfang | 8 |
| Fachzeitschrift | Journal of Pharmacology and Experimental Therapeutics |
| Jahrgang | 349 |
| Ausgabenummer | 4 |
| Publikationsstatus | Veröffentlicht - Apr. 2014 |
| Peer-Review-Status | Ja |
Externe IDs
| PubMed | 24431469 |
|---|---|
| ORCID | /0000-0003-2514-9429/work/187084984 |